Phase 1 Lymphoma Trial, Recruiting (NCT05210907)

Phase 1 Lymphoma Trial, Recruiting NCT05210907 Sponsor: Seoul National University Hospital Condition: Lymphoma

Printed from Voxsanity (voxsanity.com.au) — NCT05210907 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Lymphoma

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have a type of blood cancer called Acute Lymphoblastic Leukemia (ALL) that has come back or stopped responding to treatment, and the cancer cells test positive for a protein called CD19, and you are under 26 years old
Your leukemia has come back in the bone marrow for a second time or more, OR it has come back after a bone marrow/stem cell transplant (and it has been at least 6 months since that transplant), OR your leukemia did not go into remission after standard chemotherapy treatments, OR you are not able to have a stem cell transplant due to other serious health conditions, no suitable donor, or other medical reasons
Your cancer has been confirmed to have the CD19 protein through a lab test on bone marrow or blood samples
You are well enough to carry out some daily activities, as measured by a standard health performance score (confirm with trial site for exact score requirements)

Who may not be able to join:

You have an active, uncontrolled Hepatitis B or Hepatitis C infection that is not being managed by your doctors
You have a known HIV infection
You currently have a serious infection that is not under control with treatment
You are pregnant or currently breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

Phase 1: approximately ~10% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: +82-2-2072-3304

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05210907

Sponsor: Seoul National University Hospital

Phase: Phase 1

Status: Recruiting

Condition: Lymphoma

Trial contact: +82-2-2072-3304

More information: https://clinicaltrials.gov/study/NCT05210907

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have a type of blood cancer called Acute Lymphoblastic Leukemia (ALL) that has come back or stopped responding to treatment, and the cancer cells test positive for a protein called CD19, and you are under 26 years old
Your leukemia has come back in the bone marrow for a second time or more, OR it has come back after a bone marrow/stem cell transplant (and it has been at least 6 months since that transplant), OR your leukemia did not go into remission after standard chemotherapy treatments, OR you are not able to have a stem cell transplant due to other serious health conditions, no suitable donor, or other medical reasons
Your cancer has been confirmed to have the CD19 protein through a lab test on bone marrow or blood samples
You are well enough to carry out some daily activities, as measured by a standard health performance score (confirm with trial site for exact score requirements)

Who may not be able to join:

You have an active, uncontrolled Hepatitis B or Hepatitis C infection that is not being managed by your doctors
You have a known HIV infection
You currently have a serious infection that is not under control with treatment
You are pregnant or currently breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 1

Sponsor

Seoul National University Hospital

Registry

ClinicalTrials.gov

Start date

15 February 2022

Est. completion

30 September 2025

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

Incidence of adverse events and its severity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov